vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and McGraw Hill, Inc. (MH). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $434.2M, roughly 1.1× McGraw Hill, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -4.7%, a 11.5% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -35.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

McGraw Hill, Inc. is an American education science company that provides educational content, software, and services for students and educators across various levels—from K-12 to higher education and professional settings. They produce textbooks, digital learning tools, and adaptive technology to enhance learning experiences and outcomes. It is one of the "big three" educational publishers along with Houghton Mifflin Harcourt and Pearson Education. McGraw Hill also publishes reference and tra...

MD vs MH — Head-to-Head

Bigger by revenue
MD
MD
1.1× larger
MD
$493.8M
$434.2M
MH
Growing faster (revenue YoY)
MD
MD
+33.4% gap
MD
-1.7%
-35.1%
MH
Higher net margin
MD
MD
11.5% more per $
MD
6.8%
-4.7%
MH

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
MD
MD
MH
MH
Revenue
$493.8M
$434.2M
Net Profit
$33.7M
$-20.2M
Gross Margin
85.3%
Operating Margin
9.9%
7.0%
Net Margin
6.8%
-4.7%
Revenue YoY
-1.7%
-35.1%
Net Profit YoY
10.5%
-119.2%
EPS (diluted)
$0.40
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
MH
MH
Q4 25
$493.8M
$434.2M
Q3 25
$492.9M
$669.2M
Q2 25
$468.8M
$535.7M
Q1 25
$458.4M
Q4 24
$502.4M
Q3 24
$511.2M
Q2 24
$504.3M
Q1 24
$495.1M
Net Profit
MD
MD
MH
MH
Q4 25
$33.7M
$-20.2M
Q3 25
$71.7M
$105.3M
Q2 25
$39.3M
$502.0K
Q1 25
$20.7M
Q4 24
$30.5M
Q3 24
$19.4M
Q2 24
$-153.0M
Q1 24
$4.0M
Gross Margin
MD
MD
MH
MH
Q4 25
85.3%
Q3 25
79.2%
Q2 25
77.0%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
MD
MD
MH
MH
Q4 25
9.9%
7.0%
Q3 25
13.8%
23.4%
Q2 25
12.8%
18.0%
Q1 25
7.0%
Q4 24
7.8%
Q3 24
6.6%
Q2 24
-31.3%
Q1 24
3.2%
Net Margin
MD
MD
MH
MH
Q4 25
6.8%
-4.7%
Q3 25
14.5%
15.7%
Q2 25
8.4%
0.1%
Q1 25
4.5%
Q4 24
6.1%
Q3 24
3.8%
Q2 24
-30.3%
Q1 24
0.8%
EPS (diluted)
MD
MD
MH
MH
Q4 25
$0.40
$-0.11
Q3 25
$0.84
$0.57
Q2 25
$0.46
$0.00
Q1 25
$0.24
Q4 24
$0.37
Q3 24
$0.23
Q2 24
$-1.84
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
MH
MH
Cash + ST InvestmentsLiquidity on hand
$375.2M
$514.4M
Total DebtLower is stronger
$570.5M
$2.6B
Stockholders' EquityBook value
$865.9M
$775.3M
Total Assets
$2.2B
$5.6B
Debt / EquityLower = less leverage
0.66×
3.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
MH
MH
Q4 25
$375.2M
$514.4M
Q3 25
$340.1M
$463.2M
Q2 25
$224.7M
$247.3M
Q1 25
$99.0M
Q4 24
$229.9M
Q3 24
$103.8M
Q2 24
$19.4M
Q1 24
$8.0M
Total Debt
MD
MD
MH
MH
Q4 25
$570.5M
$2.6B
Q3 25
$577.2M
$2.8B
Q2 25
$583.9M
$3.2B
Q1 25
$590.5M
Q4 24
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MD
MD
MH
MH
Q4 25
$865.9M
$775.3M
Q3 25
$890.7M
$794.6M
Q2 25
$833.8M
$283.3M
Q1 25
$789.2M
Q4 24
$764.9M
Q3 24
$732.5M
Q2 24
$706.5M
Q1 24
$856.2M
Total Assets
MD
MD
MH
MH
Q4 25
$2.2B
$5.6B
Q3 25
$2.2B
$6.0B
Q2 25
$2.1B
$5.7B
Q1 25
$2.0B
Q4 24
$2.2B
Q3 24
$2.1B
Q2 24
$2.0B
Q1 24
$2.2B
Debt / Equity
MD
MD
MH
MH
Q4 25
0.66×
3.36×
Q3 25
0.65×
3.52×
Q2 25
0.70×
11.17×
Q1 25
0.75×
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
MH
MH
Operating Cash FlowLast quarter
$114.1M
$309.0M
Free Cash FlowOCF − Capex
$285.4M
FCF MarginFCF / Revenue
65.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
MH
MH
Q4 25
$114.1M
$309.0M
Q3 25
$137.3M
$265.0M
Q2 25
$137.2M
$-96.7M
Q1 25
$-117.5M
Q4 24
$133.0M
Q3 24
$91.8M
Q2 24
$107.0M
Q1 24
$-125.2M
Free Cash Flow
MD
MD
MH
MH
Q4 25
$285.4M
Q3 25
$243.8M
Q2 25
$-112.9M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
MD
MD
MH
MH
Q4 25
65.7%
Q3 25
36.4%
Q2 25
-21.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
MD
MD
MH
MH
Q4 25
5.4%
Q3 25
3.2%
Q2 25
3.0%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
MD
MD
MH
MH
Q4 25
3.39×
Q3 25
1.91×
2.52×
Q2 25
3.49×
-192.53×
Q1 25
-5.66×
Q4 24
4.36×
Q3 24
4.72×
Q2 24
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

MH
MH

Higher Education$225.4M52%
Digital$103.5M24%
Other$44.4M10%
Global Professional$36.2M8%
Print$24.7M6%

Related Comparisons